Search Results

Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon α.

• Authors : Dasgupta A; Department of Pediatrics.; Tsay E

Subjects: Autoimmune Diseases* ; Autoimmunity* ; Diabetes Mellitus*

• Source: Pediatrics [Pediatrics] 2022 Apr 01; Vol. 149 (4).Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print

Record details

Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome.

• Authors : Kilic SS; Department of Pediatrics, Uludag University School of Medicine, Bursa, Turkey. ; Kilicbay F

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use ; Job Syndrome/Job Syndrome/Job Syndrome/*complications

• Source: Pediatrics [Pediatrics] 2006 Jun; Vol. 117 (6), pp. e1253-1255. Date of Electronic Publication: 2006 May 01.Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model:

Record details

Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy.

• Authors : Lackner H; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Karl-Franzens-University, Graz, Austria. ; Moser A

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hematologic Neoplasms/Hematologic Neoplasms/Hematologic Neoplasms/*complications ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

• Source: Pediatrics [Pediatrics] 2000 Oct; Vol. 106 (4), pp. E53.Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print

Record details

Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon-alpha therapy.

• Authors : Ruíz-Moreno M; Department of Pediatrics, Fundación Jiménez Díaz, Madrid, Spain.; Fernández P

Subjects: Hepatitis B/Hepatitis B/Hepatitis B/*therapy ; Hepatitis, Chronic/Hepatitis, Chronic/Hepatitis, Chronic/*therapy ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use

• Source: Pediatrics [Pediatrics] 1997 Feb; Vol. 99 (2), pp. 222-5.Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print

Record details

Familial aggregation of autoimmune disease in juvenile dermatomyositis.

• Authors : Niewold TB; University of Chicago, Section of Rheumatology, Gwen Knapp Center for Lupus and Immunology Research, 924 E 57th St, R420, Chicago, IL 60637, USA. ; Wu SC

Subjects: Autoimmune Diseases/Autoimmune Diseases/Autoimmune Diseases/*genetics ; Disease Susceptibility/Disease Susceptibility/Disease Susceptibility/*epidemiology ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*metabolism Amyopathic dermatomyositis

• Source: Pediatrics [Pediatrics] 2011 May; Vol. 127 (5), pp. e1239-46. Date of Electronic Publication: 2011 Apr 18.Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model:

Record details

Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases.

• Authors : Marler JJ; Department of Surgery, Children's Hospital, Boston, Massachusetts 02115, USA.; Rubin JB

Subjects: Angiogenesis Inhibitors/Angiogenesis Inhibitors/Angiogenesis Inhibitors/*therapeutic use ; Giant Cell Tumors/Giant Cell Tumors/Giant Cell Tumors/*drug therapy ; Hemangioblastoma/Hemangioblastoma/Hemangioblastoma/*drug therapy

• Source: Pediatrics [Pediatrics] 2002 Feb; Vol. 109 (2), pp. E37.Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print

Record details

Interferon and giant cell tumors.

• Authors : Dickerman JD; Department of Pediatrics, University of Vermont, College of Medicine, Burlington, VT 05405, USA.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*drug therapy ; Giant Cell Tumors/Giant Cell Tumors/Giant Cell Tumors/*drug therapy

• Source: Pediatrics [Pediatrics] 1999 Jun; Vol. 103 (6 Pt 1), pp. 1282-3.Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print

Record details

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.

• Authors : Kaban LB; Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.; Mulliken JB

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Giant Cell Tumors/Giant Cell Tumors/Giant Cell Tumors/*drug therapy ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use

• Source: Pediatrics [Pediatrics] 1999 Jun; Vol. 103 (6 Pt 1), pp. 1145-9.Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print

Record details

Interferon-associated refractory status epilepticus.

• Authors : Miller VS; Dept of Neurology, University of Texas Southwestern Medical School.; Zwiener RJ

Subjects: Interferon-alpha/Interferon-alpha/Interferon-alpha/*adverse effects ; Status Epilepticus/Status Epilepticus/Status Epilepticus/*chemically induced; Electroencephalography

• Source: Pediatrics [Pediatrics] 1994 Mar; Vol. 93 (3), pp. 511-2.Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print

Record details

Treatment with interferon gamma versus interferons alpha and gamma in children with chronic hepatitis B

• Authors : Ruiz-Moreno, Mercedes; Rua, Maria Jose; Moraleda, Gloria

• Source: Pediatrics. August 1992, Vol. 90 Issue 2, p254, 5 p.

Record details